This inventor holds 1 USPTO granted patent. Top assignee: Biocon Limited. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations by Jithendrababu Raghunadhachetty
Introduction
Jithendrababu Raghunadhachetty is a notable inventor based in Chittoor District, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymorphic forms of Dasatinib. His work has implications for improving the efficacy and stability of this important medication.
Latest Patents
Raghunadhachetty holds 1 patent related to his invention titled "Polymorphic forms of Dasatinib." This patent encompasses the dasatinib-thymine co-crystal and dasatinib-adenine co-crystal. Additionally, it includes dasatinib-butanediol solvate and various crystalline forms of dasatinib, such as crystalline dasatinib-(±)-1, 2-Butanediol, crystalline dasatinib (R)-1, 2-Butanediol, and crystalline dasatinib (S)-1, 2-Butanediol. The invention also details processes for preparing amorphous dasatinib and anhydrous dasatinib, as well as a method for obtaining dasatinib monohydrate from anhydrous dasatinib.
Career Highlights
Jithendrababu Raghunadhachetty is currently associated with Biocon Limited, a leading biopharmaceutical company. His role at Biocon has allowed him to focus on innovative research and development in the pharmaceutical sector. His expertise in polymorphic forms of drugs has positioned him as a valuable asset in the industry.
Collaborations
Raghunadhachetty has collaborated with notable colleagues, including Ramakrishna Parameshwar Bhat and Raghavendracharyulu Venkata Palle. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of pharmaceutical research.
Conclusion
Jithendrababu Raghunadhachetty's contributions to the field of pharmaceuticals, particularly through his patent on Dasatinib, highlight his innovative spirit and dedication to improving drug formulations. His work continues to influence the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
